RESOURCES

AD/PD™ 2026

GemPharmatech will be attending AD/PD™ 2026, where we look forward to engaging with the neuroscience research community to discuss advanced preclinical solutions for neurodegenerative disease studies. Our integrated platforms are designed to support mechanistic research, drug efficacy evaluation, and translational development across Alzheimer’s disease, Parkinson’s disease, and related neurological disorders.

Neuroscience 2025

GemPharmatech is exhibiting at Society for Neuroscience's Neuroscience 2025! taking place November 16-19 in San Diego, California. Visit us at Booth 3225 to explore how our advanced neurological mouse models are accelerating discovery in Alzheimer's disease, Parkinson's disease, and other neurodegenerative disorders.

ACR Convergence 2025

GemPharmatech is proud to be returning to American College of Rheumatology (ACR) Convergence 2025 and showcase our expanding portfolio of autoimmune disease models and preclinical research capabilities!

SITC 2025

GemPharmatech is excited to be attending one of the premier global conferences advancing cancer immunotherapy, Society for Immunotherapy of Cancer (SITC)'s SITC 2025 in National Harbor, MD! We will be presenting 6 posters! Join us to explore our latest advancements in humanized mouse models and preclinical immuno-oncology research.

ADA 2025

EACR 2025

4th World ADC Asia Summit

16th FELASA Congress

FAOBMB 2025